Two massive funding deals in the life sciences segment and a pair of companies moving to the public markets were the highlights of the Atlantic Canadian startup community in the second quarter of 2019.
The biggest news was the US$30 million (C$40 million) venture capital round announced in April by Halifax medical device maker ABK Biomedical Inc., with which it hopes to bring two products to market. The funding round, led by Cambridge, Mass.-based F-Prime Capital, and Palo Alto, Calif.-based Varian Medical Systems, was the largest VC round ever announced by an Atlantic Canadian company.